Delivery Order SPE2DB24D2216-SPE2DB25FGNBK
Award Date 3/10/25
Potential Completion Date 3/31/25
Potential Value $7.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,575.75 firm-fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a medication. The contract has a period of performance through June 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance through June 25, 2025. The contract is designated as a firm fixed-price delivery order, without any set-aside requirements. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $7,575.75 and an ultimate completion date of July 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a prescription medication, with a ceiling value of $15,151.52 and a period of performance ending on May 9, 2025. The contract is not set aside and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $14,645.34 and a completion date of June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a large pharmaceutical distributor, is the prime contractor for this award. The contract is part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,322.67 firm fixed-price contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering...
- This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance ending on July 15, 2025. The contract is not set aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $33,865.10 and a completion date of May 22, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $30,303.04 and a period of performance through July 28, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...